$526,762,153

Funds Oregon's epidemiology and laboratory capacity to detect, prevent, and control emerging infectious diseases.

Strengthens U.S. disease surveillance infrastructure and rapid response capabilities for pandemic preparedness and emerging pathogen threats.

Increases demand for diagnostic equipment, laboratory reagents, and bioinformatics systems from suppliers to state health departments.

Demonstrates U.S. investment in domestic disease surveillance independent of foreign laboratory or diagnostic dependencies.